Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Television star Sarah Greene has previously revealed that her current partner was a dear friend of her late husband, Mike Smith, and she's convinced that Mike "orchestrated" their romance from the ...

ABU DHABI: Cameron Green could well be the biggest beneficiary of the IPL's skewed demand-supply market dynamic surrounding seam-bowling all-rounders during the mini-auction here on Tuesday with ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

It’s official: In a move that will dramatically reshape the entertainment business, Netflix and Warner Bros. Discovery announced an agreement Friday under which Netflix will acquire Warner Bros., ...

The bluegrass musician's mom Debra died of a drug overdose in June Rachel DeSantis is a senior writer on the music team at PEOPLE. She has been working at PEOPLE since 2019, and her work has ...

Billy Strings is opening up about the unexpected death of his mother, Debra Apostal, which happened in June. Strings — whose legal name is William Lee Apostal — says his mom wasn't sick leading up to ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 7 minutes ...

On Friday and Saturday nights, Billy Strings performed at The Orion Amphitheater in Huntsville, Ala. The concerts came after the band turned in their first night of songs in Rocket City, which brought ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...